Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer

Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer

Abstract Background Breast cancer is the most frequent cancer among women worldwide. Biomarkers for early detection and prognosis of these patients are needed. We hypothesized that deafness, autosomal dominant 5 (DFNA5) may be a valuable biomarker, based upon strong indications for its role as tumor...

Full description

Bibliographic Details
Main Authors: Lieselot Croes, Matthias Beyens, Erik Fransen, Joe Ibrahim, Wim Vanden Berghe, Arvid Suls, Marc Peeters, Patrick Pauwels, Guy Van Camp, Ken Op de Beeck
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Clinical Epigenetics
Subjects:
DFNA5
Methylation
Breast cancer
Detection biomarker
Prognostic biomarker
TCGA
Online Access:http://link.springer.com/article/10.1186/s13148-018-0479-y

Internet

http://link.springer.com/article/10.1186/s13148-018-0479-y

Similar Items